Strain AI vs Reveal LINQ
AI Verdict
Choose Strain AI if…
Choose Strain AI if you need real-time, on-device AI analysis of cardiac ultrasound images to quickly assess heart function and measure Global Longitudinal Strain (GLS). This tool is ideal for physicians evaluating adult patients for conditions like heart failure or monitoring for cardiotoxicity during ongoing treatments, providing immediate diagnostic support without manual interpretation.
View Strain AI →Choose Reveal LINQ if…
Choose Reveal LINQ if you require continuous, long-term cardiac monitoring for up to three years to detect intermittent or suspected arrhythmias. This implantable cardiac monitor is best suited for diagnosing conditions such as atrial fibrillation, cryptogenic stroke, or unexplained syncope, leveraging AI algorithms to reduce false alerts and provide comprehensive ECG data remotely.
View Reveal LINQ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Strain AI | Reveal LINQ |
|---|---|---|
| Deployment | API, Integrations with POS and menu sync platforms (Dutchie, Leafly, Weedmaps, Jane POS, Treez) | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Strain AIStrain AI integrates with existing ultrasound devices and delivers real-time, on-device AI insights, streamlining the diagnostic workflow without requiring new patient procedures. Reveal LINQ, while offering a simplified insertion, still involves an invasive procedure and a multi-component system (implant, bedside monitor, app) for ongoing use, making its overall deployment and patient management more complex.
Clinical Value
TieBoth tools offer significant and distinct clinical value. Strain AI provides quantitative GLS measurements for assessing heart function and detecting conditions like heart failure, while Reveal LINQ offers long-term continuous ECG monitoring with AI for accurate arrhythmia detection. Both are FDA-cleared and address critical needs in cardiology, making a direct comparison of 'more' valuable difficult without specific clinical context.
Pricing & Value
TieBoth tools require contacting the vendor for pricing, making a direct cost comparison impossible. While Reveal LINQ's pricing is noted to often be integrated into procedure costs and covered by insurance, this doesn't provide a clear advantage in terms of overall value without knowing the actual costs for either solution.
Enterprise Readiness
Reveal LINQMedtronic, as a global leader in medical devices, possesses a significantly more established and extensive enterprise infrastructure, including global sales, support, and integration capabilities for complex medical device ecosystems. While Strain AI offers a simpler, on-device deployment and explicit BAA, Medtronic's long-standing experience with large-scale healthcare deployments and comprehensive CareLinku2122 network give Reveal LINQ an edge in overall enterprise readiness.
Innovation
Reveal LINQReveal LINQ demonstrates a higher degree of innovation through its extreme miniaturization as the world's smallest insertable cardiac monitor, combined with long-term continuous ECG monitoring and AI-powered arrhythmia detection. Strain AI's innovation lies in bringing real-time, on-device AI to enhance existing ultrasound diagnostics, but the implantable device technology of Reveal LINQ represents a more groundbreaking advancement in medical device design and diagnostic capability.
Support & Docs
Reveal LINQMedtronic, as a large and established medical device company, offers a significantly more comprehensive and mature support infrastructure for Reveal LINQ, including extensive online resources, dedicated clinical education, field support, and patient services. While Exo provides support for Strain AI, Medtronic's global presence and experience with complex implantable devices ensure a more robust and wide-ranging support and documentation ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Strain AI | Reveal LINQ |
|---|---|---|
| Tool Name | Strain AI | Reveal LINQ |
| Primary Function | Analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS) for assessing heart function and detecting conditions. | Continuously records ECG for up to three years to detect and diagnose cardiac arrhythmias. |
| Company | Exo | Medtronic |
| AI Focus | AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS). | AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope, with reduced false alerts. |
| Monitoring Duration | Not specified | Continuous ECG monitoring for up to three years |
| Target Conditions/Assessment | Assessing heart function, detecting heart failure (CHF, HFpEF, HFrEF), hypertrophy, and cardiotoxicity in adult patients. | Detecting and diagnosing cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. |
Videos
Demos, reviews, and walkthroughs featuring Strain AI and Reveal LINQ.